Qualicorp Consulting and Insurance Brokerage (QUAL3) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
15 Jul, 2026Executive summary
Strategy centers on deleveraging, cash generation, operational efficiency, and a balanced product portfolio, with a resilient business model despite portfolio contraction.
Net revenue for 1Q25 was R$371.1 million, down 3.5% from 4Q24 and 8.1% year-over-year, with the Affinity segment accounting for over 90% of revenue.
Adjusted EBITDA rose 5.6% sequentially to R$146.4 million, with margin up to 39.5%.
Free cash flow reached BRL 142 million, supporting deleveraging and a net debt/EBITDA ratio of 1.34x.
New management and a long-term incentive plan are driving operational efficiency and portfolio revitalization.
Financial highlights
Net revenue reached R$1,597 million in 2024, down from R$2,104 million in 2023, reflecting portfolio contraction.
Adjusted EBITDA margin improved to 39.5% in 1Q25 and 31.9% in 2024, with sequential margin gains.
Free cash flow to firm was R$439 million in 2024, with cash and financial investments above R$1 billion.
Fixed expenses over revenue ratio decreased to 29.2% from the previous quarter.
Bad debt provision increased 15.1% from 4Q24, reflecting ongoing collection challenges.
Outlook and guidance
Focus on cost and expense reductions, improved margins, and profitability through operational efficiency.
Management expects continued positive organic churn trends and gradual sales recovery, with plans to increase CAC as sales accelerate.
Judicial contingency expenses expected to remain high through Q3, with reductions likely from Q4 or early 2026.
Continued deleveraging agenda with net debt/EBITDA ratio reduced to 1.34x as of March 2025.
Management is monitoring interest rate scenarios and their impact on net exposure and profitability.
Latest events from Qualicorp Consulting and Insurance Brokerage
- Churn fell to 9.4% as net revenue hit R$333.0m, with strong cash flow and lower net debt.QUAL3
Q1 202615 Jul 2026 - Net revenue and income rose, churn improved, and 340 new products were launched amid portfolio changes.QUAL3
Q3 202515 Jul 2026 - Profitability and margins improved as churn hit record lows despite revenue declines.QUAL3
Q2 202515 Jul 2026 - Adjusted net income more than doubled despite revenue decline, with strong cash flow and lower net debt.QUAL3
Q4 202415 Jul 2026 - Revenue and EBITDA fell, but net income, cash flow, and leverage improved amid portfolio contraction.QUAL3
Q3 202415 Jul 2026 - Adjusted net income surged 59% sequentially as EBITDA margin hit 45.4% despite portfolio decline.QUAL3
Q2 202415 Jul 2026 - Free cash flow and margins improved, but revenue and portfolio declined amid restructuring.QUAL3
Q4 20256 Jul 2026